Clinical Scorecard: Outcomes and Mortality Factors Following Surgical Intervention for Chronic Subdural Hematoma: Insights from the FINISH Randomized Trial Post Hoc Analysis
At a Glance
Category
Detail
Condition
Chronic subdural hematoma (CSDH), a collection of blood and degradation products due to head trauma and inflammation
Assess comorbidities including hypertension, diabetes, ischemic heart disease, dementia, and cerebrovascular history.
Management
Perform burr-hole drainage with or without subdural irrigation as per randomized trial protocols.
Exclude patients with prior intracranial surgery, coma, acute infection, or high thrombosis risk from this surgical approach.
Monitoring & Follow-up
Follow patients postoperatively for at least 6 months to monitor mortality and complications.
Use Kaplan–Meier survival analysis and Cox proportional hazards modeling to assess mortality risk factors.
Risks
Increased mortality risk with higher number of comorbidities, especially dementia (HR 5.31) and cardiac arrhythmia (HR 3.23).
Risk of death from circulatory diseases, accidents including traumatic subdural hematoma, and dementia-related causes.
Patient & Prescribing Data
Elderly patients (median age 78) undergoing burr-hole drainage for symptomatic CSDH with varying comorbidities.
Mortality rates increase with number of comorbidities; 6-month mortality post-surgery is 6.6%, overall mortality 13.9% during median 16.4 months follow-up.
Clinical Best Practices
Careful preoperative assessment of comorbidities to stratify mortality risk.
Close postoperative monitoring for complications, especially in patients with dementia and cardiac conditions.
Consider long-term follow-up due to excess mortality observed up to 20 years after CSDH diagnosis.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
